Target Pharmasolutions, Inc.

This study follows up to 500,000 adults with chronic liver disease or cirrhosis to learn how the disease progresses and how well current treatments work. Participants are observed through their regular medical care, and some are asked to provide additional information. The goal i…

This study is creating a large registry of up to 15,000 adults and children with inflammatory skin conditions like eczema, psoriasis, and vitiligo. Researchers will follow participants over time to see how treatments work in everyday medical practice and track any side effects. T…

This study is observing up to 500,000 adults with chronic gastrointestinal diseases like Crohn's disease, ulcerative colitis, and eosinophilic GI disorders. Researchers are collecting data from medical records and patient reports to understand how these diseases progress and how …

This study follows 10,000 adults with hepatocellular carcinoma (a type of liver cancer) over time to see how the disease naturally progresses and how doctors treat it in routine practice. Researchers will collect information on treatments, side effects, and quality of life. The g…

This study follows 15,000 adults and children (age 2+) with Crohn's disease, ulcerative colitis, or indeterminate colitis for up to 5 years. Researchers will collect data on how patients respond to treatments, side effects, and disease changes in everyday medical practice. The go…

This study was designed to watch and learn from people with chronic kidney disease (CKD) and end-stage kidney disease. Researchers planned to track how the disease progresses over time and how well current treatments work. However, the study was withdrawn before enrolling any par…